A group that includes UC San Francisco, the City and County of San Francisco, the San Francisco Department of Public Health (DPH), and health care and community organizations has launched the San Francisco Cancer Initiative (SF CAN), a major public health effort to reduce cancer in San Francisco.
SF CAN, conceived and supported by UCSF, aims to reduce the incidence and mortality from the most common cancers in San Francisco that are likely to be affected by known interventions or better screening. Those are prostate, breast, liver, colorectal and tobacco-related cancers. Since the majority of those cancers disproportionately affect racial and ethnic minorities, as well as the socio-economically disadvantaged, a primary focus of SF CAN will be reducing inequities in prevention, screening rates, access to quality health care and overall outcomes.
The initiative builds on a 2016 report by UCSF researchers that catalogued the state of cancer in San Francisco in 2013/2014, identifying the most prevalent types, the burden within different populations, risk and disparities among diverse communities. Robert Hiatt, MD, PhD, chair of the Department of Epidemiology and Biostatistics, authored the report.
Read more about the SF CAN initiative at ucsf.edu.